1. Deuteration of the farnesyl terminal methyl groups of δ-tocotrienol and its effects on the metabolic stability and ability of inducing G-CSF production
- Author
-
Peter A. Crooks, Daohong Zhou, Zhengya Gao, Peiyi Zhang, Xuan Zhang, Howard P. Hendrickson, Lin Song, Xingui Liu, Qiang Fu, and Guangrong Zheng
- Subjects
Male ,Metabolite ,medicine.medical_treatment ,Clinical Biochemistry ,Pharmaceutical Science ,Radiation-Protective Agents ,01 natural sciences ,Biochemistry ,Article ,Mice ,Structure-Activity Relationship ,chemistry.chemical_compound ,Pharmacokinetics ,In vivo ,Granulocyte Colony-Stimulating Factor ,Drug Discovery ,medicine ,Animals ,Vitamin E ,Potency ,Molecular Biology ,Dose-Response Relationship, Drug ,Molecular Structure ,010405 organic chemistry ,Organic Chemistry ,In vitro ,0104 chemical sciences ,Bioavailability ,010404 medicinal & biomolecular chemistry ,chemistry ,Molecular Medicine ,Tocotrienol - Abstract
δ-tocotrienol (DT3), a member of vitamin E family, has been shown to have potent radio-protective effect. However, its application as a radioprotectant has limited, at least in part, by its short plasma elimination half-life and low bioavailability. In an effort to increase the metabolic stability of DT3, a deuterium substituted DT3 derivative, d(6)-DT3, was designed and synthesized. d(6)-DT3 showed improved in vitro and in vivo metabolic stability compared to DT3. The unexpected lower potency of d(6)-DT3 in inducing granulocyte-colony stimulating factor (G-CSF) production in mouse revealed that the metabolite(s) of DT3 might play a major role in inducing G-CSF induction.
- Published
- 2020